Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease via engagement of PD-1 ligands
Alexander Hackel(University of Lübeck), Sven Brandau(University of Duisburg-Essen)
Cited by 50
Related Papers
Mesenchymal Stem Cells Augment the Anti-Bacterial Activity of Neutrophil Granulocytes
|PLoS ONE|2014|109
TNF‐α and IL‐1β sensitize human MSC for IFN‐γ signaling and enhance neutrophil recruitment
|European Journal of Immunology|2020|85
Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma
|Frontiers in Immunology|2013|30